Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Clover Health Investments, Corp. (CLOV : NSDQ)
 
 • Company Description   
Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif.

Number of Employees: 458

 
 • Price / Volume Information   
Yesterday's Closing Price: $13.83 Daily Weekly Monthly
20 Day Moving Average: 113,927,472 shares
Shares Outstanding: 408.10 (millions)
Market Capitalization: $5,644.04 (millions)
Beta:
52 Week High: $28.85
52 Week Low: $6.31
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 88.68% 86.64%
12 Week 82.94% 71.34%
Year To Date -17.53% -26.98%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
725 Cool Springs Blvd Suite 320
-
Franklin,TN 37067
USA
ph: 201-432-2133
fax: -
investors@cloverhealth.com http://www.cloverhealth.com
 
 • General Corporate Information   
Officers
Vivek Garipalli - Chief Executive Officer and Chairman of the Board
Andrew Toy - President
Joseph Wagner - Chief Financial Officer
Chelsea Clinton - Director
Lee A. Shapiro - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 18914F103
SIC: 6324
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/21
Next Expected EPS Date: 08/16/21
Share - Related Items
Shares Outstanding: 408.10
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $5,644.04 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.20 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.50 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 32.01% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/16/21  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 9.58
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: 21.04%
vs. Previous Quarter: -%
ROE
03/31/21 - -17.88
12/31/20 - -179.78
09/30/20 - -
ROA
03/31/21 - -3.19
12/31/20 - -1.07
09/30/20 - -
Current Ratio
03/31/21 - 4.68
12/31/20 - 0.83
09/30/20 - 0.33
Quick Ratio
03/31/21 - 4.68
12/31/20 - 0.83
09/30/20 - 0.33
Operating Margin
03/31/21 - -
12/31/20 - -
09/30/20 - -
Net Margin
03/31/21 - -
12/31/20 - -
09/30/20 - -
Pre-Tax Margin
03/31/21 - -77.54
12/31/20 - -
09/30/20 - -
Book Value
03/31/21 - 1.44
12/31/20 - 0.20
09/30/20 - 0.21
Inventory Turnover
03/31/21 - -
12/31/20 - -
09/30/20 - -
Debt-to-Equity
03/31/21 - 0.04
12/31/20 - 0.00
09/30/20 - 0.00
Debt-to-Capital
03/31/21 - 3.96
12/31/20 - 0.00
09/30/20 - 0.00
 

Powered by Zacks Investment Research ©